Medication adherence is associated with improved outcomes in patients with quiescent ulcerative colitis (UC).

被引：4

作者：

Kane, SV ^{[1
]}

Hanauer, SB ^{[1
]}

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

来源：

GASTROENTEROLOGY | 2000年 / 118卷 / 04期

关键词：

D O I：

10.1016/S0016-5085(00)85683-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4900

引用

页码：A886 / A886

页数：1

共 50 条

[11] Once daily mesalamine results in improved adherence and comparable outcomes versus conventional dosing in quiescent ulcerative colitis: A pilot study [J].

Kane, SV ;

Magnanti, K .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09) :S230-S231

[12] Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis [J].

Kitae, Hiroaki ;

Takagi, Tomohisa ;

Naito, Yuji ;

Inoue, Ryo ;

Azuma, Yuka ;

Torii, Takashi ;

Mizushima, Katsura ;

Doi, Toshifumi ;

Inoue, Ken ;

Dohi, Osamu ;

Yoshida, Naohisa ;

Kamada, Kazuhiro ;

Uchiyama, Kazuhiko ;

Ishikawa, Takeshi ;

Konishi, Hideyuki ;

Itoh, Yoshito .

MICROORGANISMS, 2022, 10 (05)

[13] ABDOMINAL PAIN AND ASSOCIATED FACTORS IN ACTIVE AND QUIESCENT ULCERATIVE COLITIS PATIENTS [J].

van Gils, Tom ;

Tornblom, Hans ;

Jonefjall, Borje ;

Strid, Hans ;

Simren, Magnus .

GASTROENTEROLOGY, 2024, 166 (05) :S254-S255

[14] Patients' and Gastroenterologists' Preferences on Outcomes and Medication Attributes for Ulcerative colitis [J].

Katsoula, A. ;

Paschos, P. ;

Giouleme, O. ;

Toumbalidou, M. ;

Mainou, M. ;

Malandris, K. ;

Tsapas, A. .

JOURNAL OF CROHNS & COLITIS, 2024, 18 :I1927-I1927

[15] IS URINARY DRUG EXCRETION IN SPOT SAMPLES FROM PATIENTS WITH ULCERATIVE COLITIS (UC), AN OBJECTIVE MEASURE OF 5-ASA MEDICATION ADHERENCE? [J].

Moshkovska, T. ;

Ismail, E. ;

Diu, T. ;

Smith, R. M. ;

Mayberry, J. F. .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 :124-124

[16] Rectal hypersensitivity in patients with quiescent ulcerative colitis [J].

Casanova, M. J. ;

Santander, C. ;

Gisbert, J. P. .

JOURNAL OF CROHNS & COLITIS, 2015, 9 (07) :592-592

[17] Conveying medication benefits to ulcerative colitis patients: what thresholds for adherence are applied? [J].

Selinger, Christian ;

Kinjo, Yu ;

Mclaughlin, John ;

Robinson, Andrew ;

Leong, Rupert W. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 :117-118

[18] CONVEYING MEDICATION BENEFITS TO ULCERATIVE COLITIS PATIENTS: WHAT THRESHOLDS FOR ADHERENCE ARE APPLIED? [J].

Selinger, C. ;

Kinjo, Y. ;

McLaughlin, J. ;

Robinson, A. ;

Leong, R. .

GUT, 2012, 61 :A172-A173

[19] Concomitant Use of Aminosalicylates Is Not Associated With Improved Outcomes in Patients With Ulcerative Colitis Escalated to Vedolizumab [J].

Ma, Christopher ;

Kotze, Paulo G. ;

Almutairdi, Abdulelah ;

Jairath, Vipul ;

Panaccione, Remo .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (11) :2374-+

[20] Sonographic healing is not associated with improved long-term outcomes in patients with ulcerative colitis [J].

Vaughan, R. ;

Tjandra, D. ;

Mingos, N. ;

Gibson, R. ;

Boussioutas, A. ;

Al-Ani, A. ;

Gibson, P. ;

Christensen, B. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 :124-125

← 1 2 3 4 5 →